Moreover, PACAP’s protective effects in MNs during ALS progression could be direct through PAC1R activation or mediated by EGFR trans-activation promoting MAPK or PI3K signaling survival cascade (Figure 5). Here, ADCYAP1R1 is linked to amyotrophic lateral sclerosis.